News
The Food and Drug Administration is again trying to rehire some staffers who were recently fired amid mass layoffs at the ...
In an exclusive interview with physician and writer Dr. Jeremy Faust on Substack, Makary opened up about his first weeks on ...
Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore communication for ...
7hOpinion
Medpage Today on MSNInside the FDA: Low Morale and Uncertainty Plague StaffSeveral current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...
A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
2dOpinion
MedPage Today on MSNA Conversation With FDA Commissioner Marty MakaryAmong other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results